Global Cancer Vaccines Pipeline Analysis
Upcoming SlideShare
Loading in...5
×
 

Global Cancer Vaccines Pipeline Analysis

on

  • 128 views

“Global Cancer Vaccines Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various vaccines being developed for the treatment of multiple cancers. Research report covers all the ...

“Global Cancer Vaccines Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various vaccines being developed for the treatment of multiple cancers. Research report covers all the ongoing vaccines being developed in various development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the cancer vaccine market based upon development process.

For Report Sample Contact: rajesh@pnspharma.com

Statistics

Views

Total Views
128
Views on SlideShare
126
Embed Views
2

Actions

Likes
0
Downloads
1
Comments
0

1 Embed 2

http://www.scoop.it 2

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Global Cancer Vaccines Pipeline Analysis Global Cancer Vaccines Pipeline Analysis Document Transcript

  • Global Cancer Vaccines Pipeline Analysis Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized. North America has the largest share of the overall vaccines and specifically cancer vaccines market. This is followed by Europe and Asia. North America and Europe are expected to grow at a steady pace in the years to come. However, India and China are expected to see a boost in demand over the next 10 years, owing to their ageing populations and the prevalence of various infectious diseases. “Global Cancer Vaccines Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various vaccines being developed for the treatment of multiple cancers. Research report covers all the ongoing vaccines being developed in various development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the cancer vaccine market based upon development process. For Report Sample Contact: rajesh@pnspharma.com Following parameters for each vaccine profile in development phase are covered in “Global Cancer Vaccines Pipeline Analysis” research report: • Drug Profile Overview • Alternate Names for Drug • Active Indication • Phase of Development • Mechanism of Action • Brand Name • Patent Information • Orphan Designation by Indication, Country & Organisation • Country for Clinical Trial • Owner / Originator/ Licensee/Collaborator
  • • Administrative Route • Drug Class • ATC Codes Breakup of Cancer Vaccines by Development Phase: • Research: 9 • Preclinical: 75 • Phase-I: 42 • Phase-I/II: 32 • Phase-II: 43 • Phase-II/III: 6 • Phase-III: 19 • Preregistration: 2 • Marketed: 12 For Report Sample Contact: rajesh@pnspharma.com Each Drug Profile has Tables Representing Following Information: * Alternate names * Originator & Owner * Collaborator * Technology Provider * Licensee * Development phase * Active Development - Indications * Class * Mechanism of Action * ATC code * Allocated Brand Name & Orphan Designation